The news of Susquehanna maintaining a Positive rating on Endava but lowering the price target from $104 to $100 may not have a significant short-term impact on the stock price. The lowered price target still indicates a positive outlook for the company, but investors may take note of the reduced target and adjust their expectations accordingly. The relevance and importance of this news are high, as it directly pertains to Endava and its stock price, but the short-term impact is neutral.